IMUGENE CHART. TA only, page-25191

I still don’t understand why the market should pricing a complete failing of the company.

we haven’t received any negative updates, someone is just making assumptions based on nothing about the CR.
whoever is complaint on this forum is either someone wants to scare investors away or people that wants to be rich overnight.

it’s a biotech company, the run research, studies in the medical field, we cannot expect news every minute.
as Prof YF said, they are forced by FDA to release just some of the info, not all, and we certainly won’t make FDA upset, don’t we?
If only one of you could explain to all of us why this company is failing, we would very appreciate it.

just my opinion not financial advice